Search

  • Sort by

  • Category

  • Post Type

  • Reset

Badger State Sheriffs’ Association, Wisconsin State Sherrifs Association, Letters to Representatives Greg Walden and Frank Pallone, July 1, 2019

July 18, 2019
Posted in ,
Read More

Pharmalogical, Inc – screenshot from homepage, 2010

July 17, 2019
Read More

Pharmalogical, inc homepage

July 17, 2019
Read More
Pharmalogical, Inc - screenshot from homepage, 2010

Medical Device King Exec Takes a Plea Deal Instead of a Retrial; Gets 32 Months in Prison

July 17, 2019
Posted in ,

New York-based Pharmalogical, Inc. (d/b/a Medical Device King and Taranis Medical Corp.) grossed $17 million by misleading U.S. medical practices into believing they were buying FDA-approved products rather than “unapproved products imported through a series of unidentified middlemen in Turkey and elsewhere.” President William Scully, was convicted of these activities in 2015, but the conviction was vacated in 2017. In 2018, he pleaded guilty, and was sentenced to 32 months in prison.

Read More

Son Chu Gilliam Statement of Facts

July 17, 2019
Read More

Florida State Senator Compares Supporting Drug Importation to Believing in the Tooth Fairy

July 17, 2019
Posted in

This editorial by Perry Thurston Jr. was published in Florida Politics on July 16, 2019. In it, State Senator Thurston explains that state-implemented drug importation will not bring any medication cost savings to Floridians.

Read More

Thurston

July 17, 2019

Source: Florida Senate

Read More

Medical Device King website, 2011

July 17, 2019

Screen shot of MDK’s website, September 2011: “…we only offer
brand products from FDA approved and registered facilities.”
(Source: The Wayback Machine)

Read More

Portion of MDK Warning Letter, May 13, 2013

July 17, 2019

The FDA warned 780 MDK customers about counterfeit Altuzan,
non-FDA approved Aclasta and MabThera, and these 31
additional products.

Read More

New Analysis by HDA Finds Importation Proposals Are Too Expensive and Pose Health Risks to Patients

July 16, 2019
Posted in , ,

A report just released the HDA Research Foundation demonstrates that federal importation proposals to allow drug importation are devoid of practical implementation guidance and funding, so will fail to guarantee federal safety and quality standards for prescription medication.

Read More